Trials / Unknown
UnknownNCT02296281
Safety and Efficacy Study of Pirfenidone to Treat Grade 2 or Above Radiation-induced Lung Injury
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of pirfenidone capsules to treat grade 2 or above radiation-induced lung injury patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pirfenidone |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-06-01
- First posted
- 2014-11-20
- Last updated
- 2014-11-20
Source: ClinicalTrials.gov record NCT02296281. Inclusion in this directory is not an endorsement.